• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸通过激活TRAIL死亡诱导信号复合物,使人肝癌细胞对TRAIL诱导的凋亡敏感。

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.

作者信息

Carlisi Daniela, Lauricella Marianna, D'Anneo Antonella, Emanuele Sonia, Angileri Liliana, Di Fazio Pietro, Santulli Andrea, Vento Renza, Tesoriere Giovanni

机构信息

Dipartimento di Scienze Biochimiche, Università di Palermo, Policlinico, Palermo 90127, Italy.

出版信息

Eur J Cancer. 2009 Sep;45(13):2425-38. doi: 10.1016/j.ejca.2009.06.024. Epub 2009 Jul 28.

DOI:10.1016/j.ejca.2009.06.024
PMID:19643600
Abstract

This paper shows that the histone deacetylase inhibitor SAHA sensitised at sub-toxic doses human hepatocellular carcinoma cells (HepG2, Hep3B and SK-Hep1) to TRAIL-induced apoptosis, while it was ineffective in primary human hepatocytes (PHHs). In particular in HCC cells SAHA increased the expression of death receptor 5 (DR5) and caused a decrement of c-Flip. These two modifications provoked in the presence of TRAIL the rapid production of TRAIL-DISC and the activation of caspase-8. Consequently SAHA/TRAIL combination induced many apoptotic events, such as a cleavage of Bid into tBid, dissipation of mitochondrial membrane potential, activation of caspase-3 with the consequent cleavage of both NF-kB and Akt. The decrease in NF-kB level seemed to be responsible for the reduction in the content of IAP family antiapoptotic proteins while the decrease in Akt level caused a reduction in phospho-Bad. These events led to the activation of caspase-9, which contributed to the strong apoptotic activity of TRAIL. Sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by SAHA may suggest new strategies for the treatment of liver tumours.

摘要

本文表明,组蛋白去乙酰化酶抑制剂SAHA在亚毒性剂量下可使人类肝癌细胞(HepG2、Hep3B和SK-Hep1)对TRAIL诱导的凋亡敏感,而在原代人肝细胞(PHHs)中则无效。特别是在肝癌细胞中,SAHA增加了死亡受体5(DR5)的表达,并导致c-Flip减少。在TRAIL存在的情况下,这两种修饰引发了TRAIL-DISC的快速产生和半胱天冬酶-8的激活。因此,SAHA/TRAIL组合诱导了许多凋亡事件,如Bid裂解为tBid、线粒体膜电位消散、半胱天冬酶-3激活以及随后NF-κB和Akt的裂解。NF-κB水平的降低似乎是IAP家族抗凋亡蛋白含量减少的原因,而Akt水平的降低导致磷酸化Bad减少。这些事件导致了半胱天冬酶-9的激活,这有助于TRAIL的强大凋亡活性。SAHA使人类肝癌细胞对TRAIL诱导的凋亡敏感,这可能为肝癌治疗提出新的策略。

相似文献

1
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸通过激活TRAIL死亡诱导信号复合物,使人肝癌细胞对TRAIL诱导的凋亡敏感。
Eur J Cancer. 2009 Sep;45(13):2425-38. doi: 10.1016/j.ejca.2009.06.024. Epub 2009 Jul 28.
2
Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.槲皮素通过Sp1介导的DR5上调和蛋白酶体介导的c-FLIPS下调,使人肝癌细胞对TRAIL诱导的凋亡敏感。
J Cell Biochem. 2008 Dec 15;105(6):1386-98. doi: 10.1002/jcb.21958.
3
COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.环氧化酶-2抑制剂使人类肝癌细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡敏感。
Int J Mol Med. 2006 Jul;18(1):41-7.
4
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.SAHA可诱导肝癌细胞凋亡,并与蛋白酶体抑制剂硼替佐米协同作用。
Apoptosis. 2007 Jul;12(7):1327-38. doi: 10.1007/s10495-007-0063-y.
5
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.磷酸化Akt的下调是硼替佐米诱导肝癌细胞凋亡的主要分子决定因素。
Cancer Res. 2008 Aug 15;68(16):6698-707. doi: 10.1158/0008-5472.CAN-08-0257.
6
Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.人原代T淋巴细胞中对TRAIL诱导凋亡的抗性调节:NF-κB抑制的作用
Mol Immunol. 2007 Apr;44(10):2587-97. doi: 10.1016/j.molimm.2006.12.015. Epub 2007 Jan 25.
7
Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.曲古抑菌素A通过抑制表皮生长因子受体(EGFR)途径下调细胞凋亡抑制蛋白长型(c-FLIPL),使人卵巢癌细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡敏感。
Biochem Pharmacol. 2009 Apr 15;77(8):1328-36. doi: 10.1016/j.bcp.2008.12.027. Epub 2009 Jan 24.
8
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.腺病毒介导的肿瘤坏死因子相关凋亡诱导配体(Ad-hTRAIL)与达卡巴嗪(DTIC)或伏立诺他(SAHA)联合治疗与人类黑色素瘤细胞系中线粒体介导的细胞凋亡增加有关。
J Gene Med. 2007 Jun;9(6):440-51. doi: 10.1002/jgm.1036.
9
Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.罗格列酮通过活性氧介导的死亡受体5上调和c-FLIP下调促进肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡。
Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. doi: 10.1016/j.freeradbiomed.2007.12.001. Epub 2007 Dec 8.
10
The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.细胞周期蛋白依赖性激酶抑制剂黄酮哌醇使人类肝癌细胞对TRAIL诱导的凋亡敏感。
Int J Mol Med. 2006 Aug;18(2):249-56.

引用本文的文献

1
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma.靶向半胱天冬酶-8:一种对抗肝细胞癌的新策略。
Front Immunol. 2024 Dec 12;15:1501659. doi: 10.3389/fimmu.2024.1501659. eCollection 2024.
2
Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors.人结直肠癌细胞获得性肿瘤坏死因子相关凋亡诱导配体(TRAIL)耐药与组蛋白乙酰化有关,并与组蛋白去乙酰化酶抑制剂联合使用可协同改善。
Dig Dis Sci. 2024 Sep;69(9):3305-3317. doi: 10.1007/s10620-024-08569-5. Epub 2024 Aug 1.
3
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells.
琥珀酰亚胺基戊二酰羟肟酸上调自噬受体表达并促进肝癌细胞死亡。
World J Gastroenterol. 2023 Sep 14;29(34):5038-5053. doi: 10.3748/wjg.v29.i34.5038.
4
The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy-Apoptosis Molecular Crosstalk.地西他滨和伏立诺他联合用药通过自噬-凋亡分子串扰的表观遗传调控对人肝癌HepG2细胞系产生协同抗肿瘤作用
Curr Issues Mol Biol. 2023 Jul 16;45(7):5935-5949. doi: 10.3390/cimb45070375.
5
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases.组蛋白去乙酰化酶抑制剂:肿瘤治疗、免疫调节及肺部疾病的靶点
Transl Oncol. 2022 Feb;16:101312. doi: 10.1016/j.tranon.2021.101312. Epub 2021 Dec 16.
6
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives.组蛋白去乙酰化酶抑制剂的抗癌治疗:基于机制的联合策略及未来展望
Cancers (Basel). 2021 Feb 5;13(4):634. doi: 10.3390/cancers13040634.
7
Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.表观遗传学:肝细胞癌中表观遗传调节剂和潜在治疗方法的综述。
Biomed Res Int. 2020 Nov 24;2020:9593254. doi: 10.1155/2020/9593254. eCollection 2020.
8
New landscapes and horizons in hepatocellular carcinoma therapy.肝细胞癌治疗的新领域和新前景。
Aging (Albany NY). 2020 Feb 4;12(3):3053-3094. doi: 10.18632/aging.102777.
9
Zebularine and trichostatin A sensitized human breast adenocarcinoma cells towards tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis.泽布勒林和曲古抑菌素A使人类乳腺腺癌细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡敏感。
Heliyon. 2019 Sep 19;5(9):e02468. doi: 10.1016/j.heliyon.2019.e02468. eCollection 2019 Sep.
10
Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy.肿瘤坏死因子相关凋亡诱导配体(TRAIL)信号传导的表观遗传调控:对癌症治疗的意义
Cancers (Basel). 2019 Jun 19;11(6):850. doi: 10.3390/cancers11060850.